Quest Intl., Inc. FDA Record
- No warning letters matched by name
Quest Intl., Inc. has 0 FDA recalls, 0 inspections, 25 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Quest Intl., Inc." is on file.
- Latest 510(k)
- Jun 8, 2009
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 25 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 0 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
Reviewing Quest Intl., Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Quest Intl., Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K091260 | SERAQUEST EBV EA-D IGG TEST | Jun 8, 2009 |
| K033915 | MODIFICATION TO SERAQUEST EB VCA IGG | Jan 16, 2004 |
| K033780 | MODIFICATION TO SERAQUEST VCA IGM | Jan 15, 2004 |
| K023593 | SERAQUEST ANTI-THYROID PEROXIDASE (TPO) | Feb 6, 2003 |
| K023592 | SERAQUEST ANTI-THYROGLOBULIN | Jan 6, 2003 |
| K003069 | ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM | Nov 27, 2000 |
| K991975 | SERAQUEST EB NA IGG | Nov 2, 1999 |
| K990410 | SERAQUEST EB VCA IGG | Oct 28, 1999 |
| K990977 | SERAQUEST EB VAC IGM | Oct 6, 1999 |
| K982485 | SERAQUEST CMV IGM | Jan 13, 1999 |
| K982281 | SERAQUEST RUBELLA IGM | Oct 16, 1998 |
| K980639 | SERAQUEST ANTI-SSB | Jun 15, 1998 |
| K980540 | SERAQUEST ANTI-SM | Jun 15, 1998 |
| K980810 | SERAQUEST ANTI-SSA | May 12, 1998 |
| K980811 | SERAQUEST ANTI-SM/RNP | May 12, 1998 |
| K980391 | SERAQUEST ANTI-DSDNA | Apr 24, 1998 |
| K980059 | SERAQUEST MUMPS IGG | Apr 23, 1998 |
| K972295 | SERAQUEST VZV IGG | Nov 5, 1997 |
| K971672 | SERAQUEST TOXOPLASMA IGM | Oct 21, 1997 |
| K963282 | SERAQUEST HSV IGG | Jan 22, 1997 |
Quest Intl., Inc. and the FDA: common questions
Has Quest Intl., Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Quest Intl., Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Quest Intl., Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Quest Intl., Inc." in its reading room. FDA publishes some Form 483s, not all of them.
Need more than this page shows? Ask about Quest Intl., Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.